Can you provide a SOAP note for a 48‑year‑old female presenting with low libido, mild vaginal atrophy, and work‑related stress?

SOAP Note: 48-Year-Old Female with Low Libido

Subjective

Chief Complaint: Low libido

History of Present Illness:

• Duration and onset of decreased sexual desire
• Associated symptoms: vaginal dryness, dyspareunia, difficulty with arousal or orgasm
• Work-related stress level and impact on daily functioning
• Presence of anxiety, depression, or mood changes
• Hot flashes, night sweats, or other menopausal symptoms
• Sleep quality and disturbances
• Relationship satisfaction and partner communication
• Body image concerns
• Current medications (particularly antidepressants, antihypertensives, or hormonal therapies)

Past Medical History:

• Menstrual history: last menstrual period, regularity, perimenopausal symptoms
• History of breast cancer, endometrial cancer, or other hormone-sensitive malignancies
• Prior chemotherapy, radiation, or surgical menopause
• Chronic medical conditions (diabetes, cardiovascular disease, thyroid disorders)
• History of sexual trauma or abuse

Medications: Document all current medications, particularly those affecting sexual function

Social History:

• Smoking status
• Alcohol use
• Relationship status and quality
• Work stress factors

Objective

Vital Signs: Blood pressure, heart rate, BMI

Physical Examination:

• General: Affect, signs of anxiety or depression
• Thyroid: Palpation for enlargement or nodules
• Breast: Clinical breast exam if indicated
• Pelvic examination:
  • External genitalia: Signs of atrophy, skin changes, lesions
  • Vaginal mucosa: Pallor, dryness, friability, loss of rugae
  • Vaginal pH (if available): >5.0 suggests atrophy
  • Pelvic floor muscle tone and tenderness
  • Cervix and uterus assessment

Laboratory (if indicated by history/exam):

• TSH if thyroid symptoms present
• Fasting glucose if metabolic concerns
• Note: Serum testosterone and other hormone levels are NOT routinely indicated for diagnosis of low libido 1

Assessment

Primary Diagnosis: Female Sexual Interest/Arousal Disorder (low libido) in perimenopausal/postmenopausal woman

Contributing Factors:

• Physiologic: Menopausal hypoestrogenism with vaginal atrophy
• Psychological: Work-related stress, possible anxiety
• Interpersonal: (assess relationship factors)

Differential Considerations:

• Hypothyroidism
• Depression
• Medication-induced sexual dysfunction
• Relationship discord

Plan

For Low Libido (Primary Concern):

First-Line Approach:

1. Address psychological and stress factors 2:

   • Recommend cognitive behavioral therapy (CBT) - proven effective for improving sexual function 2
   • Consider referral for sexual counseling or couples therapy 3
   • Discuss integrative therapies: yoga and meditation to alleviate anxiety impacting sexual function 2

2. Pharmacologic options for low desire 2:

   • Bupropion (off-label): Consider trial, particularly if depressive symptoms present 4
   • Flibanserin or bremelanotide: FDA-approved for hypoactive sexual desire disorder in premenopausal women; discuss risks/benefits including side effects (dizziness, somnolence, nausea) 2, 5, 2
   • Buspirone: Alternative option to discuss 2

For Vaginal Atrophy/Dryness:

Sequential Treatment Approach 3, 6:

1. First-line (start here):

   • Water-based or silicone-based vaginal lubricants for sexual activity 3, 7
   • Vaginal moisturizers used at least twice weekly (not just during intercourse) 3, 7

2. Second-line (if non-hormonal therapies insufficient):

   • Low-dose vaginal estrogen (tablets, cream, or ring): Most effective treatment for vaginal dryness and dyspareunia 2, 7
     • No progestogen needed with low-dose vaginal estrogen 7
     • Results typically take 6-12 weeks 3
     • Long-term safety data beyond 1 year limited 8

   OR

   • Vaginal DHEA (prasterone): Alternative for vaginal dryness and dyspareunia 2
     • Improves sexual desire, arousal, and pain 2
     • No progestogen needed 8

3. Alternative oral option:

   • Ospemifene 60mg daily: Selective estrogen receptor modulator for moderate-to-severe dyspareunia due to vaginal atrophy 2, 7
     • Contraindicated if history of breast cancer or estrogen-dependent malignancy 7

Additional Interventions:

• Pelvic floor physical therapy: Improves sexual pain, arousal, lubrication, orgasm, and satisfaction 2
• Vaginal dilators: If dyspareunia or stenosis present 2
• Topical lidocaine: For dyspareunia (apply to vulvar vestibule before penetration) 2

For Work-Related Stress:

• Stress management techniques
• Consider mental health referral if anxiety/depression screening positive
• Lifestyle modifications: adequate sleep, regular exercise

Patient Education:

• Sexual dysfunction in menopause is multifactorial (hormonal, psychological, interpersonal) 2
• Treatment requires addressing multiple contributing factors simultaneously
• Vaginal atrophy is chronic and progressive without treatment 9, 10
• Combination of counseling, over-the-counter treatments, and pharmacologic options most effective 3

Follow-up:

• Re-evaluate at 6-8 weeks to assess treatment response
• If no improvement by 6 months, consider medication cessation or alternative approaches 1
• Monitor for any postmenopausal bleeding if using vaginal estrogen (requires prompt endometrial evaluation) 7
• Regular interval reassessment of sexual function 2

Referrals:

• Sexual health specialist or gynecologist if symptoms persist despite initial interventions 2
• Mental health professional for CBT or intensive psychotherapy 3
• Pelvic floor physical therapist 2

Common Pitfalls to Avoid:

• Do not order serum testosterone or hormone panels routinely - they do not correlate with sexual dysfunction severity and have no diagnostic threshold 1, 4
• Do not use systemic hormone therapy solely for low libido without vasomotor symptoms 4
• Do not add progestogen to low-dose vaginal estrogen or DHEA 7, 8
• Do not use ospemifene in women with breast cancer history 7